identified (12) ; each encodes a protein corresponding to a fusion between the amino-terminal region of the M-MuLV gag gene product and a polypeptide encoded by the mouse cell-derived sequences (12) (13) (14) . These proteins have molecular weights ranging from 160,000 to 90,000. The prototype A-MuLV strain encodes a 120,000 molecular weight protein called P120. We use the notation A-MuLV-P120 to denote this strain. P120 is a phosphorylated nonglycosylated protein, of which a portion is exposed on the exterior of the plasma cell membrane of infected cells (15) .
When P120 or the other A-MuLV proteins are incubated in vitro with [y-32P]ATP, radioactive phosphate is transferred to one or more tyrosine residues in the protein (16) . This behavior is similar to the protein kinase activities (EC 2.7.1.37) associated with the Rous sarcoma virus src gene product and the middle T (tumor) antigen of polyoma virus (17) (18) (19) . Because of the close association of tyrosine-phosphorylating activity with transforming proteins and also because the A-MuLV fusion proteins are the only known gene products of the A-MuLV genome (11) , we have assumed that these proteins are responsible for transformation by the various A-MuLV strains. No direct genetic or biochemical data have yet appeared to support this assumption. The identification of the transforming gene of Rous sarcoma virus, src, and its gene product, pp60src, was greatly aided by the isolation of transformation-defective (td) mutants (20) .
Because Rous sarcoma virus contains genes for replicative functions, assays that detected expression of replication genes in the absence of transformation could be used to identify such mutants. In the case of A-MuLV (and other defective transforming retroviruses) there are no linked functional replication genes that can be used in the section of td mutants. As an alternative one can search for cells that express A-MuLV antigens but are not transformed (21) . By such screening procedures, we have isolated a spontaneous td mutant of A-MuLV. It encodes an antigenically recognizable A-MuLV protein, but the protein lacks the associated protein kinase activity found in proteins from transforming strains of A-MuLV. The coincident loss of kinase activity and transforming potential lends strong support to the hypothesis that the A-MuLV protein is a transforming gene product that may function as a protein kinase.
MATERIALS AND METHODS
Cell Lines and Viruses. The cell lines used and their derivations were: ANN-1 (A-MuLV-P120-transformed nonproducer NIH/3T3 mouse fibroblast); A2 (A-MuLV-P120-transformed nonproducer NIH/3T3 fibroblast that has changed to producing P90 and P92); 2M3 (A-MuLV-P120-transformed nonproducer lymphoid cell from BALB/c bone marrow); and NIH/3T3 uninfected fibroblasts. Cell lines superinfected with M-MuLV are designated as /M (as in 2M3/M). All cells were cultured as described (22, 23) . Assays for helper virus plaqueforming units (24) , A-MuLV focus-forming units in fibroblasts (5) , and A-MuLV lymphoid cell transformation (22, 23) (13, 15, (25) (26) (27) .
In Vitro Kinase Activity. Immunoprecipitates of A-MuLV proteins were tested for kinase activity in a Mn2+-activated assay as described (16 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 77 (1980) RESULTS Isolation of an A-MuLV td Mutant. The A-MuLV td mutants arose during the study of a particular A-MuLV stock. The stock was prepared from the A2 cell line, an A-MuLV-P120-transformed nonproducer line derived by A. Shields after single cell-single virus infection of NIH/3T3 cells with a stock of A-MuLV from ANN-1/M cells (10) . Originally, the A2 cell line expressed the A-MuLV P120 protein as its only MuLV-related product, but on continued passage over 2 years smaller serologically related polypeptides appeared in the cells and ultimately P120 became undetectable. The major A-MuLV-related polypeptide in the cells became one of 90,000-92,000 molecular weight.
A stock of A-MuLV was prepared by superinfection of these late-passage A2 cells with M-MuLV to give the A2/M cell line. NIH/3T3 cells were then infected with the A2/M stock at a multiplicity of infection of about 0.5 focus-forming units per cell and distributed at about 0.3 cell per microwell. Clones were screened morphologically and both transformed and nontransformed clones were selected and tested for synthesis of A-MuLV and M-MuLV proteins by metabolic labeling and immunoprecipitation. Of 75% grew into macroscopic colonies (1-to 3-mm diameter) within 2-2.5 weeks. F1-3 cells plated under identical conditions showed no macroscopic colonies after 3 weeks. If the plates were refed weekly, however, and the incubation was continued for [5] [6] weeks, small colonies (0.5-to 1-mm diameter) representing about 10% of the initially seeded cells were visible. Uninfected NIH/3T3 cells showed no colonies under such conditions. Four of these Fl-3-derived colonies were picked, and when grown on tissue culture plastic dishes they showed the same growth properties as the parent Fl-3 cells. These microcolonies may result from some residual expression of the A-MuLV transforming function.
Serological Comparison of A-MuLV Protein from Tx-15 and F1-3.Celis. To examine the A-MuLV-related proteins made by Tx-15 and Fl-S cells, the cells were labeled with [35S]methionine, and immunoprecipitated products were analyzed by NaDodSO4/polyacrylamide gel electrophoresis. When a mouse antiserum known to react with the A-MuLV-specific region of the A-MuLV protein (15) was used for immunoprecipitation in the presence of an excess of unlabeled M-MuLV proteins, a 90,000-92,000 molecular weight protein was found in both lines (Fig. 2, lanes B) . Normal mouse serum did not precipitate this protein (lanes A). A polyvalent goat anti-M-MuLV serum also precipitated the 90,000-92,000 molecular weight proteins (lanes C) but revealed no helper virus proteins. Sometimes, the 90,000-92,000 molecular weight region from Tx-15 cells was resolved into two separate components, called P90 (monitored by fluorography) were recovered from equal numbers of Fl-S or Tx-15 cells (Fig. 3, lanes A and B) . Somewhat smaller apparent breakdown products of P90 and P92 were also present, as seen previously for most A-MuLV proteins (13 (Fig. 3, lane E) the P160-containing extract (lane G), then both P160 and P92 were labeled. Thus P92 has a phosphate acceptor site as measured in this coprecipitation assay. A similar set of reactions using Tx-15 extract showed that, in unheated preparations, P90 was labeled with phosphate (lane H), that the activity could be heat-inactivated (lane I), and that heat-inactivated P90 could be labeled when mixed with a p160-containing extract (lane J). The extract with P160 alone labeled only the 160,000 molecular weight protein (lane K). In other experiments (data not shown) P92 was unable to phosphorylate another heat-inactivated A-MuLV protein such as P160 in similar coprecipitation kinase tests.
The Defective Transfonnation Phenotype of Fl-S Cells Is a Viral Not a Cellular Defect. To examine whether the lack of transformed phenotype and kinase activity in Fl-3 cells was due to an abnormal cellular rather than viral function, F1-3 cells and NIH/3T3 cells were infected with wild-type A-MuLV stocks. After 2 hr of exposure to the virus, the cells were removed from the dish with trypsin and suspended in agar at 500 Microbiology: Witte et al. qR Proc. Nati. Acad. Sci. USA 77 (1980) cells per 10-cm plate. Macroscopic agar colonies were counted after 2 weeks. Not only could the Fl-3 cells be transformed by superinfection with a second A-MuLV strain, but the number of agar colonies was 3-5 times greater than on control NIH/3Th cells. In addition, the average size of the colonies of superinfected Fl-3 cells was 2-3 times that of infected NIH/3T3 cells. This enhancement was found for wild-type A-MuLV stocks that make P90, P120, and P160 proteins. The precise mechanism for this increased number of agar colonies is unclear, but the A-MuLV genome in Fl-S cells might provide a complementary function to other A-MuLV strains.
To determine if an altered viral genome was responsible for the transformation-defective phenotype of Fl-3 cells, we infected Fl-S3 Tx-15, and 2M3-a control A-MuLV-P120-transformed cell line-with M-MuLV and assayed the rescued AMuLV genomes for fibroblast and lymphoid cell transforming capability ( Table 2 ). The virus from Fl-S cells showed no ability to transform either fibroblast or lymphoid cells. All three virus stocks, however, showed high levels of helper virus, indicating no block to retrovirus multiplication in Fl-S cells. The A-MuLV stocks from Tx-15 and 2M3 cells showed normal levels of fibroblast transformation but the Tx-15 virus, although able to transform lymphoid cells, was much less efficient in this assay than the 2M3-derived virus. Reduced lymphoid cell transforming ability by another A-MuLV-P90 strain has been observed (unpublished data).
The lack of transformation by the virus stock rescued from Fl-S cells could be a consequence of either an inability to rescue any A-MuLV genome from F1-S cells or an intrinsic transformation defect in a rescued A-MuLV genome from the cells. To determine if an A-MuLV-P92td genome was rescued from Fl-S cells and passed to NIH/3T3 cells, we assayed for the presence of the 92,000 molecular weight A-MuLV-specific protein in cells infected by the virus stock rescued from Fl-3 cells. When NIH/3T3 cells were mass infected with an undiluted Fl-3/M stock and allowed to grow for 4 days, no alteration of growth morphology was evident compared to uninfected NIH/3T3 cells. Two days later the cells were labeled for 1 hr with [M5SI-methionine, extracted, and clarified for immunoprecipitation. As expected, the cells contained all three of the major helper M-MuLV precursor proteins (29) : Pr65gag, Pr8Oent, and Prl80gag-Pol (Fig. 4, lanes C-F) . In addition, they contained a 92,000 molecular weight band that contained both AMuLV-specific determinants-monitored by precipitation with anti-Abelson tumor serum (15) (Fig. 4, lane B) -and gag gene determinants (lanes C, E, and F). Thus, in the absence of passage of any transforming ability, we could demonstrate the We were able to isolate A-MuLV-P92td because it still expressed a protein with both gag and A-MuLV-specific determinants. The mutation that gave rise to A-MuLV-P92td inactivated both its kinase activity and its transforming ability. In the absence of a total genetic analysis of the A-MuLV-P92td genome, we cannot be certain that it has only a single defect, but, by preliminary restriction enzyme analysis of its DNA provirus, it appears to have suffered a single 700-base deletion of the A-MuLV-P120 genome in the A-MuLV-specific region of the genome. On the assumption that this deletion is the only alteration in A-MuLV-P92td compared to A-MuLV-P120, the concomitant loss of kinase activity and transforming activity clearly associates these two parameters. Significantly, the P92 protein can still serve as a substrate for the kinase found in AMuLV-transformed cellk Thus the mutation in A-MuLV-P92td has separated the kinase activity associated with the A-MuLV protein from the ability of the protein to act as a substrate for phosphorylation. One interpretation of this dissociation of functions is that separate regions of A-MuLV-transforming proteins are involved in kinase and substrate activity and that at least the kinase activity is required for transformation. We cannot rule out, however, that the A-MuLV protein induces a cellular kinase and that the induction function is defective in A-MuLV-P92td.
Similarities exist between the A-MuLV protein and the avian sarcoma virus src gene product, although they have different cellular targets for transformation. Both are found in cell membrane fractions (15, 30) and both appear to catalyze protein kinase reactions that result in the formation of phosphotyrosine (16, 19) . src-containing viruses can transform fibroblasts but not hematopoietic cells. A-MuLV, by contrast, transforms lymphoid cells as well as NIH/3T3 "fibroblasts," but it does not transform primary fibroblasts and its only activity in animals is transformation of hematopoietic cells (mainly lymphoid cells) (7) . Proteins of other retroviruses and DNA tumor viruses also have been associated with protein kinase activity (18, (31) (32) (33) (34) (35) . How these membrane-associated kinase activities are related to the transforming ability of the viruses remains to be determined, but the commonality of properties of these transforming proteins is remarkable.
The number of A-MuLV strains making different sizes of protein is increasing and has required the development of the somewhat cumbersome nomenclature used in this paper. There is still at least one imprecision in the protein designation used here. P90 from Fl-3 cells and Tx-15 cells is presumably the same protein but we do not know if it is the same as a P90 previously described (12) . The new P90 should be designated P9OA unless an exact correspondence to the previous P90 can be shown. They may be identical, however, because both viruses making these proteins arose from the A-MuLV-P120 strain, although independently; both arose as a consequence of a small change in the A-MuLV-P120 genome, presumably causing the appearance of a new termination codon (unpublished data); and both are relatively deficient for lymphoid as opposed to fibroblast transformation (Table 2 ; unpublished data). 
